PhRMA Lifts Its Torch With Public/Private OMOP Initiative
Executive Summary
A major effort of the Pharmaceutical Research and Manufacturers of America in the development of data- mining techniques is the Observational Medical Outcomes Partnerships, a two-year public/private research initiative that began in early 2009 and aims to develop tools to analyze existing databases to identify and evaluate safety and benefits of drugs already on the market.